ANGO Financial Facts

Cost of sales: 48.75M
Operating income: -10.15M
See Full Income Statement

DEFERRED INCOME TAXES, long term: 16.47M
Accrued liabilities: 19.95M
See Full Balance Sheet

AngioDynamics (ANGO) Earnings

  |   Expand Research on ANGO
Next EPS Date 10/9/15 *Est. EPS Growth Rate -22.2% *Last Qtr.
Average EPS % Beat Rate +8.4% Revenue Growth Rate -3.4% *Last Qtr.
Average % Move 1-Wk after EPS -4.9% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
7/23/14 Q414 $0.18$0.12 +$0.06$94.1M$93.65M Details
7/16/15 Q415 $0.14$0.14 $0.00$90.9M$91.67M = Details
1/8/15 Q215 $0.17$0.15 +$0.02$92.1M$90.9M Details
4/9/15 Q315 $0.12$0.16 -$0.04$86.6M$89.8M Details
1/9/14 Q214 $0.14$0.07 +$0.07$88.6M$87.54M N/A Details
1/3/13 Q213 $0.10$0.09 +$0.01$87M$87.4M = Details
4/9/14 Q314 $0.16$0.09 +$0.07$88.2M$86.85M N/A Details
7/11/13 Q413 $0.07$0.06 +$0.01$90M$86.43M N/A Details